Avatrombopag

Indication

Avatrombopag for treating thrombocytopenia in people with chronic liver disease needing a planned invasive procedure (TA 626)

Red

Brand:

Nice TA:

626

Commissioning responsibility:

CCG

PbR excluded:

Yes

BNF chapter:

Blood and Nutrition

Background

1.1 Avatrombopag is recommended, within its marketing authorisation, as an option for treating severe thrombocytopenia (that is, a platelet count of below 50,000 platelets per microlitre of blood) in adults with chronic liver disease having a planned invasive procedure.

Recommendation

LSCMMG Recommendation:

Red

Reason for decision:

Specialist medicine

Supporting documents:

Decisions of Lancashire local decision making groups

BwD	BP	CSR	EL	FW	GP	MB	WL
Red	Red	Red	Red	Red	Red	Red	Red

What do the colours mean?

Last Updated: 13 - Jul - 2020